a r t i c l e s Molecular chaperones of the Hsp70 family have central roles in protein folding and the maintenance of protein homeostasis 1 . Hsp70 interacts, in an ATP-dependent reaction cycle, with hydrophobic sequence elements around seven amino acids in length that are exposed by non-native proteins 2 . Substrate binding and release is regulated by J-domain cochaperones and NEFs 3,4 . In the ATP-bound state of Hsp70, the peptide-binding cleft in the C-terminal substratebinding domain (SBD) is in an open conformation, and the SBD is tightly associated with the N-terminal nucleotide-binding domain (NBD) [4] [5] [6] . Both on and off rates for peptide binding are fast 1, 3 . J proteins stimulate ATP hydrolysis by Hsp70 and induce a shift of the SBD to the closed conformation, to produce stable substrate complexes (slow on and off rates for peptide binding). The NBD and the SBD of Hsp70 are flexibly tethered in the ADP-bound conformation 7 . A group of structurally diverse NEFs trigger ADP dissociation and facilitate peptide release upon rebinding of ATP [8] [9] [10] [11] , and this allows folding of the substrate or its transfer to other machinery of protein quality control 1 . Unsuccessful folding or substrate transfer results in rebinding to Hsp70 and prevention of aggregation.
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Animals, plants and protozoa contain an additional regulator of the Hsp70 reaction cycle, the cytosolic Hsp70-interacting protein Hip (also named p48 and suppressor of tumorigenicity, ST13). Hip, a dimer of ~40-kDa subunits with chaperone activity, has been suggested to delay substrate release by slowing the dissociation of ADP from Hsp70 (refs. 12, 13) . Hip was originally identified as an interaction partner of the NBD of rat Hsc70 in a yeast two-hybrid assay 12 . It was independently identified as a component of a complex of immature progesterone receptor associated with Hsp70, Hsp90 and the adaptor protein Hsp70-Hsp90 organizing protein (Hop, also Sti1) 14 . Hip is thought to be composed of five structural segments, an N-terminal dimerization module, a TPR domain, a highly charged segment, a region composed of several GGMP peptide repeats and a C-terminal DP domain (also termed Sti1 homology domain) [15] [16] [17] (Fig. 1a) . The TPR repeats and the highly charged segment mediate interactions with the Hsp70 NBD [15] [16] [17] . The C-terminal DP domain, which is homologous to segments in Hop, was implicated in glucocorticoid-receptor maturation and presumably mediates substrate binding to Hip 18, 19 . In collaboration with Hsp70, Hip prevents the formation of cytotoxic aggregates of α-synuclein and a polyglutamine (polyQ)-expanded mutant of androgen receptor, hallmarks of Parkinson's disease and spinobulbar muscular atrophy (Kennedy's disease), respectively 20, 21 . More recently, Hip was also implicated in the ubiquitylation and proteasomal degradation of neuronal nitric oxide synthase and polyQ androgen receptor 22 . Notably, a similar effect in promoting the degradation of polyQ androgen receptor and of hyperphosphorylated Tau was achieved by the Hsp70-binding compounds MKT-077 and YM-1. These chemically related compounds stabilize substrate-Hsp70 complexes and have been described as mimics of Hip function 22, 23 .
To clarify the structural basis for the cellular function of Hip, we characterized the interaction of Hip with Hsp70 in detail, using X-ray crystallography and biochemical analysis. We find that Hip has a strong preference for Hsp70 in the ADP-bound state. A 2.7-Å cocrystal structure of the TPR core of Hip with the Hsp70 ATPase domain reveals the molecular basis for stabilization of ADP binding to the nucleotide-binding cleft. We show further that Hip and NEF binding to Hsp70 are mutually exclusive, and thus the association of Hip with Hsp70-substrate complexes attenuates their active cycling. The function of Hip in vivo depends on dimerization and the presence of the C-terminal segments. This suggests that Hip a r t i c l e s preferentially targets and stabilizes Hsp70-substrate complexes containing multiple Hsp70 molecules. This mechanism can explain how Hip cooperates with Hsp70 in aggregation prevention and facilitates the transfer of specific client proteins to downstream chaperones or the proteasome.
RESULTS

Selectivity of Hip for the ADP-bound state of Hsp70
To gain insight into the mechanism by which Hip modulates the Hsp70 reaction cycle, we analyzed the interaction of Hip with different nucleotide-bound states of Hsp70 by isothermal titration calorimetry (ITC). These experiments were performed with rat Hip and human Hsp70, which share 97.4% sequence identity. Hip had a strong preference for ADP-bound Hsp70 (K d = 8 µM) relative to the nucleotidefree chaperone (K d = 51 µM) (Fig. 1b and Supplementary Fig. 1a) , a result suggesting that Hip functionally counteracts the effect of NEFs, which displace ADP and stabilize the nucleotide-free state of Hsp70. The interaction with Hip appeared to be strongly impaired by ATP-induced conformational changes in Hsp70. In the presence of ATP, the interaction of Hip with the ATPase-inactive mutant T204A was too weak for proper quantification (Supplementary Fig. 1b) . This mutant adopts the ATP-bound conformation in which the NBD and SBD are associated, but it does not hydrolyze ATP 5, 24 .
The moderate affinity of Hip to Hsp70-ADP (K d = 8 µM) would suggest that additional contacts must enhance the interaction to allow Hip to effectively compete the binding of NEFs, which all display substantially higher affinity (K d ~0.1 µM) for Hsp70. The ITC binding curves indicated that one Hip dimer binds two molecules of Hsp70-ADP. We found no evidence for any interference between the Hsp70-binding sites in the Hip dimer. Thus, avidity effects might enhance complex formation with Hsp70, whereby interactions of Hip with Hsp70-bound substrate protein may contribute to the strength of the association.
Delineation of the Hsp70-binding domain of Hip
Hip consists of an N-terminal dimerization domain (HipN), a middle segment (HipM) containing a predicted TPR domain and a putative C-terminal substrate-binding region combining a GGMP repeat segment and a DP domain 15, 16 (Fig. 1a) . To identify the module that mediates the interaction with the NBD of Hsp70 (ref. 12), we generated a series of truncation constructs of Hip on the basis of sequence conservation ( Supplementary Fig. 2a,b) . Using ITC, we measured essentially the same affinity of full-length Hip for the ADP-bound NBD of human Hsp70 (Hsp70N) (K d = 6 µM) as for full-length Hsp70-ADP (K d = 8 µM) (Fig. 1b and Supplementary Fig. 1c) . Thus, the SBD of Hsp70-ADP did not detectably contribute to the interactions with Hip (at least in the absence of Hsp70-bound substrate). We observed similar affinities for Hsp70-ADP with Hip 78-267 (K d = 9 µM) and with HipM 78-247 (K d = 27 µM) ( Fig. 1c and  Supplementary Fig. 1d ). These truncation constructs contained the predicted TPR domain (residues 107-241) with conserved flanking segments but lacked the N-terminal dimerization domain and the putative C-terminal substrate-binding region. Further C-terminal truncation in Hip 78-234 strongly diminished the affinity to Hsp70N-ADP (K d = 102 µM) (Supplementary Fig. 1e) .
Hip is thought to stabilize the ADP-bound conformation of Hsp70 (ref. 12). We used the fluorescent ADP analog MABA-ADP as a reporter to monitor nucleotide dissociation from the NBD of Hsp70. In the absence of phosphate, the spontaneous MABA-ADP off rate was ~0.34 s −1 at 30 °C ( Fig. 1d and Supplementary Fig. 1f) . At an equimolar concentration relative to Hsp70N (1.25 µM), Hip lowered the ADP dissociation rate only marginally, but a substantial decrease in k off (to ~0.13 s −1 ) was observed when a large (40-fold) excess of Hip over Hsp70N was used ( Fig. 1d and Supplementary  Fig. 1g ). We measured a similar effect on ADP dissociation for HipM, whereas HipN and the DP domain were inactive (Fig. 1d) . The ability of Hip truncation mutants to attenuate MABA-ADP dissociation from Hsp70N correlated with their binding affinity to Hsp70N-ADP, as expected (Fig. 1c,d and Supplementary Fig. 1c-e) .
To estimate the maximal effect of Hip on nucleotide dissociation under saturation conditions, we generated fusion proteins of HipM and Hsp70N. When Hsp70N was fused to the C terminus of HipM (HipM-Hsp70N) by a nine-residue linker (Supplementary Fig. 2b) npg a r t i c l e s value of 0.02 s −1 (Fig. 1e) , a result suggesting that there is room for enhancement of the functional effect of Hip by mechanisms stabilizing the Hip-Hsp70 complex. In contrast, when the domain order was reversed (Hsp70N-HipM), the k off remained close to the spontaneous off rate, a result indicating that the fused proteins failed to form a functional intramolecular interface in this orientation (Fig. 1e ).
Structural analysis of Hip
Attempts to crystallize full-length Hip were unsuccessful. We therefore resorted to determining the crystal structures of individual Hip segments ( Table 1 ) and solved the structure of the dimerization domain (HipN) at 1.1-Å resolution. It showed a compact, α-helical dimer with each subunit contributing three helices positioned at nearly 90° angles (Fig. 2a) . For HipM, we obtained two crystal forms diffracting to 2.6 Å and 2.8 Å. As predicted, this region contained a TPR module consisting of three TPR repeats (residues 107-211) 
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The location of a hydrophobic groove in the DP domain is indicated. npg a r t i c l e s and a capping helix (α10; residues 214-241) extending from the core of the domain (Fig. 2b) . The irregularly structured segment preceding the TPR repeats (residues 78-106) was firmly attached to the TPR core by extensive hydrophobic and polar contacts, thus bringing N-and C-terminal segments into proximity (Fig. 2b) . The DP domain failed to crystallize but could be modeled on the basis of the crystal structure of the DP1 domain of Hop 19 ( Fig. 2c) . In the homology model, the helices of the DP domain formed a hydrophobic groove, perhaps a binding site for exposed hydrophobic segments of non-native substrate proteins. Analysis by small-angle X-ray scattering (SAXS) indicated an elongated conformation of the complete ~80-kDa Hip dimer with a maximum extension of ~200 Å in the distance-pair-distribution function (Supplementary Note and Supplementary Fig. 3a) , consistent with previous observations 13, 25 . The SAXS data together with CD measurements suggested the presence of substantial structural disorder, presumably contributed by the long, negatively charged sequences linking the structured domains ( Supplementary Fig. 3b,c) . This disorder may provide the conformational flexibility for Hip to recognize a wide range of Hsp70-substrate protein complexes. A tentative model for the overall organization of the Hip dimer is shown in Figure 2c .
Structure of the Hip-Hsp70 core complex
When attempts to cocrystallize Hip 78-267 or HipM with Hsp70N failed, often because apo-Hsp70N crystallized alone (data not shown), we decided to use the fusion proteins of HipM and Hsp70N to obtain structural insight into the interaction. Although the functional HipM-Hsp70N fusion protein did not crystallize, we succeeded in obtaining crystals diffracting to 2.7 Å for Hsp70N-HipM (Table 1) , which was not functional in the MABA-ADP release assay (Fig. 1c) . The fused Hsp70N and HipM domains were tightly associated in the crystal structure, burying 949 Å 2 of surface area. However, this interface proved to be only poorly conserved, and this suggests that it is without functional relevance. The interaction is apparently forced by proximity and by favorable contacts to the artificial linker ( Supplementary Fig. 4a,b) . Serendipitously, a 1,039-Å 2 crystal contact between symmetry mates of the fusion protein in the crystal lattice provided a promising candidate for the functionally relevant interface ( Fig. 3a and Supplementary Fig. 4c) . As described below, we confirmed the functional significance of this interface by mutational analysis. It involves the surface of HipM with the highest conservation score (residues 176-181 and 210-214), which contacts subdomains IA, IB and IIB of Hsp70N (Fig. 3b) . The conformation of Hsp70N in complex with HipM was virtually identical to that of the ADP-Mg-P i complex of the NBD of bovine Hsc70 (PDB 1HPM (ref. 26) , with the nucleotide being deeply buried in the center of the structure (Supplementary Fig. 4d ). The NBD of Hsp70 is thought to be conformationally dynamic, with subdomain IIB acting as a mobile gate for the nucleotide 27 . The Hsp70N-HipM crystal structure showed that Hip forms a bracket over the NBD, thus arresting the otherwise mobile subdomain IIB in a closed conformation and locking the nucleotide in the binding pocket ( Supplementary  Fig. 5a,b) . A comparison with the recently solved crystal structure of bacterial Hsp70 and DnaK in complex with ATP explained why Hip did not interact with this conformational state 5 ( Supplementary  Fig. 5c ). ATP binding induces a twist between lobes I and II of the Hsp70 NBD, which would result in a large (4-Å) relative shift between the Hip-binding surfaces on subdomains IIB, IB and IA, respectively. Thus, Hip can no longer interact with both lobes simultaneously. Furthermore, in the ATP state the three-helix bundle domain of the Hsp70 SBD would clash with the N-terminal region of HipM (Supplementary Fig. 5c ).
The conformation of HipM in complex with Hsp70N was virtually indistinguishable from that of the isolated domain, a result suggesting that the surface of HipM for Hsp70 binding is preformed (Supplementary Fig. 4e) . The HipM-Hsp70N interface involved the edge of the TPR domain that was complementary in shape with the contour of the Hsp70 nucleotide-binding cleft (Fig. 3b) . This interaction npg a r t i c l e s differed markedly from that of other TPR modules, most of which bind extended peptides at the inner face of the TPR solenoid 28 . The interface comprised a large number of polar interactions. Asn177 of HipM formed a hydrogen bond with Glu283 in Hsp70N, and aspartates 179 and 211 engaged in salt bridges to arginines 269 and 262 in Hsp70N, respectively (Fig. 3c) . Tyr212 of HipM was in van der Waals contact with residues Asn57, Gln58 and Leu61 in lobe IB of Hsp70N. Leu210 formed hydrophobic contacts to residues Arg269 and Thr265 of Hsp70N. The interaction of the TPR core domain with subdomains IA, IB and IIB of Hsp70N was reinforced by contacts of the elongated terminal helix α10 of Hip with subdomain IA (Fig. 3c) . This rather shallow interface appeared to be stabilized by electrostatic interactions between numerous basic residues, sequence HRRKYERKR, at the C terminus of helix α10 and the helix dipole of helix α4 in Hsp70N.
Mutational analysis of the Hip-Hsp70 interface
We next performed a mutational analysis of HipM to evaluate the functional significance of the conserved interface between HipM and Hsp70N in the crystal structure. Mutations N177K, N177A D179A, L210S and D211K Y212A in the central region of the interface resulted in a loss of the ability of HipM to slow the dissociation of MABA-ADP from Hsp70N ( Fig. 3d and Supplementary Fig. 4f ). The mutation N177K resulted in weak binding to Hsp70N-ADP, and the double mutant D211K Y212A resulted in virtually complete loss of binding in ITC experiments (Supplementary Fig. 4g ). Notably, mutation L210S (L211S in human Hip) was previously identified in a screen for loss-of-function mutants of human Hip 29 . Mutants K117A, R235A K236D and ∆235-247 exhibited a milder functional impairment consistent with the peripheral location of these residues in the interface. In contrast, the double mutation H196S E199A at the nonconserved intramolecular interface of the Hsp70N-HipM fusion had no effect on HipM activity ( Fig. 3d and Supplementary Fig. 4f ), a result confirming that this interface is not functionally relevant. Ser180 of Hip, located within the functional Hsp70N-HipM interface, was previously identified as a cell cycle-dependent phosphorylation site 30 . Indeed, we found the phosphomimetic mutation S180E to be inactive (Fig. 3d) . Furthermore, we could confirm that the previously described mutant I148A exhibits increased Hsp70 binding 31 (Fig. 3d) . Ile148 was also located in the functional interface with Hsp70N, and the mutation apparently enhanced polar contacts of Lys117 and Lys152 with Asp292, Tyr294 and Asp285 of Hsp70N, respectively. That the I148A mutation has not been selected for during evolution suggests that in vivo the affinity of Hip for Hsp70 must be carefully balanced with that of other Hsp70 regulators. npg a r t i c l e s the Hsp70N-HipM core-complex structure revealed that the NEFand Hip-binding areas on Hsp70N largely overlap, and this suggests mutually exclusive binding [32] [33] [34] [35] [36] [37] (Fig. 4a) . Indeed, when we added Hsp110, Bag or HspBP1 to a MABA-ADP complex of the functional HipM-Hsp70N fusion protein, we observed essentially no acceleration of MABA-ADP release (Fig. 4b) . However, the NEF effect was restored by introduction of the double mutation D211K Y212A in Hsp70N-HipM, which disrupted the functional interface in HipM ( Fig. 4b and Supplementary Fig. 4f ). Free Hip cannot efficiently interfere with the binding of NEFs, owing to their high affinity for Hsp70 (refs. 11,35,36) (Fig. 4c) . Thus, we propose a model in which avidity effects enable the Hip dimer to effectively compete with NEF binding.
Antagonism between Hip and NEFs
Hip function in vivo
To evaluate the functional relevance of dimerization and of the putative substrate-binding region of Hip, we analyzed the Hsp70 and Hsp90-dependent maturation of glucocorticoid receptor in Saccharomyces cerevisiae upon expression of Hip 31 . In this established model system lacking endogenous Hip, glucocorticoid-receptor activity is measured by the expression of a steroid-dependent β-galactosidase reporter (Fig. 5a) . Almost complete conservation of the Hip contact residues in the yeast Hsp70s Ssa1 and Ssa2 suggested that mammalian Hip interacts functionally with yeast Hsp70. At limiting hormone levels, Hip expression increased the reporter activity approximately three-fold, a result reflecting the ability of Hip to enhance the conformational maturation of glucocorticoid receptor (Fig. 5b) . In accordance with previous findings, the monomeric construct Hip had significantly reduced activity (Fig. 5b) , although the protein was expressed similarly to wild-type Hip (Supplementary Fig. 6 ) 31 . This finding suggested that avidity plays an important part in the interaction of Hip with Hsp70-substrate complexes. In addition, direct contacts of the substrate with the two arms of Hip might be important. This notion would be supported by the poor in vivo activity of Hip , which lacks the putative substrate-binding region but preserves normal MABA-ADP release activity with Hsp70N in vitro (Figs. 1d and 5b) . Mutants L210S, D211K Y212A and R235A K236D, targeting the HipHsp70 interface, also strongly diminished the ability of Hip to support glucocorticoid-receptor activation (Fig. 5b) . Thus, Hip requires dimerization, the interaction with the NBD of Hsp70 and presumably also substrate binding capacity for in vivo functionality.
DISCUSSION
Hip is so far the only known Hsp70 cochaperone that stabilizes Hsp70-client protein complexes by retarding the dissociation of ADP from Hsp70. As revealed by our structural analysis, the TPR domain of Hip forms a bracket over the Hsp70 NBD, thus reducing its otherwise dynamic nature and locking the ADP-bound state. Moreover, Hip directly counteracts the binding of NEFs to the NBD. Although the interaction between Hip and substrate-free Hsp70 appears to be largely, if not exclusively, mediated by the TPR domain of Hip (HipM) and the NBD, it occurs with an affinity too low to be biologically relevant. Our findings therefore suggest that to effectively compete NEF binding to the NBD, the Hip dimer would have to interact simultaneously with two Hsp70 molecules bound to different regions of the same substrate protein or to Hsp70s associated with small protein aggregates (which may be more likely for the 140-residue protein α-synuclein 21 ) (Fig. 6) . Future experiments will have to test this element of the model. The binding of multiple Hsp70 molecules may reflect the requirement of a specific substrate protein for prolonged chaperone stabilization. Thus, conformational properties of the client protein would determine the extent to which Hip decelerates Hsp70 cycling. Prolonged residence on Hsp70, mediated by Hip, may prevent aggregation or facilitate substrate transfer to downstream chaperones or to the degradation machinery. Hip may cooperate in these transfer steps with additional factors, such as Hop and the ubiquitin ligase CHIP, which target the C-terminal EEVD motif of Hsp70 (refs. 38,39) and direct substrates to Hsp90 and the proteasome, respectively (Fig. 6) . Phosphorylation of Hip at serine residues adjacent to its Hsp70-binding domain and within the DP domain probably modulates the activity of Hip 40, 41 to provide additional regulation of substrate flux. Increasing the level of Hip has been shown to reduce pathologic protein aggregation in cellular models of Parkinson's and Huntington's diseases 20, 21 . Enhancing Hip activity or mimicking its effect on Hsp70 pharmacologically 22 may prove useful in facilitating the proteolytic clearance of toxic, aggregation-prone proteins. Similarly, boosting Hip function might be advantageous in cancer therapy 42 by accelerating the clearance of metastable, oncogenic mutant proteins. Given that mammalian cells possess multiple isoforms of J proteins and different types of NEFs in the same compartment, it will be informative to see whether retardation of ADP release from Hsp70 is also used more extensively in the regulation of protein quality control.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Cloning of expression constructs. Constructs of rat Hip were cloned into pETM30 (Hip and Hip 312-368 ) and pProEx-HtB (Invitrogen, for all other constructs) for expression as N-terminal His 6 -tagged fusion proteins in E. coli between NcoI and HindIII or EheI and HindIII restriction sites, respectively. Point mutants were produced by PCR-based mutagenesis 44 . The pProEx-HtA expression constructs for Hsp70N (human Hsp70, residues 1-382, point mutation D110E) and Hsp70 were previously described 45 . The Hsp70(T204A) mutant was produced by PCR-based mutagenesis 44 . For construction of the Hsp70N-HipM fusion protein, XhoI restriction sites were introduced by PCR at the 3′ end of Hsp70N and at the beginning of Hip 78-247 (HipM). The EcoRI/ XhoI-and XhoI/HindIII-digested PCR products were subsequently inserted into pProEx-HtA digested with EcoRI and HindIII. The nine-residue linker sequence, GAGGGSGGS, in HipM-Hsp70N was constructed by PCR introducing a BamHI site. For cloning the Hip constructs into the yeast expression plasmid p423ADH, SpeI and EcoRI restriction sites were introduced into Hip constructs by PCR. All plasmid inserts were verified by DNA sequencing.
Protein expression and purification. E. coli Bl21-CodonPlus-RIL cells (Novagen) were transformed with the respective expression plasmids. The resulting strains were grown at 37 °C in LB medium containing 0.1 mg ml −1 ampicillin (pProEx) or 0.025 mg ml −1 kanamycin (pETM30) and 0.034 mg ml −1 chloramphenicol. At an OD 600 of 0.6, protein expression was induced with 0.5 mM IPTG, and cells were subsequently grown at 37 °C for 3 h (Hip and Hip 312-368 ) or at 18 °C for 16 h (all other constructs). His 6 -tagged proteins were isolated on Ni 2+ -chelating Sepharose (GE Healthcare) by standard procedures. For cleavage of the His 6 tag, the protein was incubated with TEV protease at a mass ratio of 1:100 in the presence of 1 mM DTT and 0.5 mM EDTA overnight at 4 °C. Residual His 6 -tagged protein and TEV protease were removed on Ni 2+ -chelating Sepharose. When necessary, additional anion-exchange chromatography was performed on a MonoQ column (GE Healthcare). Size-exclusion chromatography on Superdex-200 (GE Healthcare) equilibrated with 20 mM HEPES KOH, pH 7.4, and 100 mM KCl was used as the final purification step. Purified proteins were flash frozen in liquid nitrogen and stored at −80 °C. Hsp70N was purified as previously described 35 . Hsp70 and Hsp70(T204A) were expressed in E. coli Bl21-CodonPlus-RIL cells for 16 h at 18 °C upon induction with 0.2 mM IPTG. The purification was performed as above but in the presence of 40 mM HEPES KOH, pH 7.4, 500 mM KCl, 20 mM MgCl 2 , 5% glycerol, 2 mM β-mercaptoethanol and 5 mM ATP. For removal of ADP, Hsp70 was treated with calf intestinal alkaline phosphatase (3 U/mg Hsp70) (CIP, New England BioLabs) for 3 h at room temperature and on ice overnight. CIP was removed by size-exclusion chromatography on Superdex 200. Protein concentrations were determined by absorbance at 280 nm.
Crystallization and data collection. For Hip , initial crystals were obtained with the pH Clear Suite (Qiagen) crystallization screen at 18 °C. Final crystals grew at 22 mg ml −1 in a hanging-drop setup with 2.52 M sodium malonate, pH 7.0, as a reservoir solution. For cryoprotection, crystals were briefly dipped into 2.5 M sodium malonate, pH 7.0, containing 20% glycerol and cryocooled in liquid nitrogen.
For Hip 78-247 (HipM), initial crystals were obtained by the pH Clear Suite crystallization screen at 18 °C. Crystals of space group P4 3 2 1 2 (crystal form I) grew in the presence of 2.3 M sodium malonate, pH 6.0. Crystal form II was obtained by the hanging-drop method with a reservoir containing 2.15 M sodium malonate, pH 7.0, at 18 °C. This was the prevalent crystal form of HipM. All crystals of HipM were transferred stepwise into cryosolutions containing 2.5 M sodium malonate and 15% glycerol.
For Hsp70N-HipM, initial crystals were observed in the PEGs Suite (Qiagen) screen. Large crystals were obtained by the hanging-drop method with a reservoir containing 17% PEG-3350 and 0.2 M NH 4 I at 18 °C. The crystals were transferred in two steps into a cryosolution containing 20% PEG-3350, 0.2 M NH 4 I and 15% glycerol.
Structure determination. Diffraction data were collected at beamlines ID14-4, ID23-1, ID23-2 and ID29 of ESRF Grenoble, France. The data were integrated with XDS 46 , converted to CCP4 format with Pointless 47 and scaled with Scala 48 as implemented in the CCP4i interface 49 .
For Hip , the structure was solved by Hg-SIRAS from an ethyl mercury phosphate derivative by SHELX-CDE 50 . Two mercury sites were identified with SHELXD. The SHELXE electron density map at 1.1 Å was interpretable at atomic detail. The unit cell contains a dimer of Hip .
For crystal form I of HipM (space group P4 3 2 1 2), the native data set was soaked with hydroxymercuribenzoic acid. However, the mercury ligand, if present, was disordered in the structure. The structure was solved by Os-SIRAS from a K 2 [OsO 4 ] derivative with SHELX-CDE as implemented in HKL2MAP, at 5.6-Å resolution 51 . Sharp was used to refine the three heavy-atom sites and for calculating initial phases 52 . Phase extension and density modification was performed with Resolve, resulting in an interpretable electron density map 53 . The unit cell contains two copies of HipM, which are symmetrically associated by interactions of helix α9 with helices α8 and α9 of the opposing molecule. Residues 78-93 and 213-247 are disordered in both copies.
For crystal form II of HipM (space group P2 1 ), we initially integrated the diffraction data in the orthorhombic space group C222 1 with lattice parameters of 68.9, 91.4 and 126.6 Å and solved the structure by molecular replacement with the Hip 78-247 -fragment coordinates from the Hsp70N-HipM fusion protein as a search template with Molrep 54 . However, refinement failed to lower the R factors. The true space group was P2 1 with very similar lattice parameters a and c and the data substantially twinned. The unit cell contained four copies of HipM. Residues 82-241 were ordered in all chains.
For Hsp70N-HipM fusion protein, the structure was solved by molecular replacement in Molrep with the Hsp70 1-393 -ADP complex and the HipM monomer from crystal form I as search templates. Residues 1-550, including residues 1-382 of human Hsp70 and residues 78-243 of rat Hip, were defined in the density as well as ADP-P i -Mg 2+ and 17 iodine ions. The positions of 17 resolved iodine ions from the precipitant solution were confirmed from the anomalous signal in a data set collected from a different crystal at 2.0-Å wavelength.
All models were built interactively with Coot 55 . Refinement was performed with Refmac 56 . Residues (apart from glycine) facing solvent channels were modeled as alanines when side chain density was not discernible.
Isothermal titration calorimetry.
The respective binding partners were dialyzed against 20 mM HEPES KOH, pH 7.4, and 100 mM KCl (ITC buffer). When indicated, 1 mM ADP was added to the Hsp70 component before dialysis.
The experiment was performed with a MicroCal VP-ITC at 22 °C by injecting 8-µl aliquots of Hip variant concentrate (1.38-1.66 mM) into the calorimeter chamber containing 1.36 ml of the Hsp70 construct in complex with the respective nucleotide (164-214 µM). When indicated, ATP was present at 5 mM. Caloric titration data were analyzed by the Hip protomer concentration.
Nucleotide-release measurements. Nucleotide release kinetics of the fluorescent nucleotide analog MABA-ADP, enzymatically prepared from MABA-ATP (8-[(4-(N-methyl-anthraniloyl)-amino)butyl]-amino-adenosine-5′-triphosphate, Na salt, Interchim), was followed with a SX.18V stopped-flow instrument (Applied Photophysics) as previously described 33, 57 . All components were in 20 mM HEPES KOH, pH 7.4, 100 mM KCl and 1 mM MgCl 2 buffer containing 1 mM DTT. MABA-ADP complexes were formed by mixing 2.5 µM Hsp70N or an Hsp70N fusion protein with an equimolar concentration of MABA-ADP and incubating at 30 °C for 30 min. The nucleotide-exchange solutions contained 250 µM ATP and protein factors as indicated. To determine the nucleotide release rates, equal volumes of the solutions were mixed at 30 °C in the stopped-flow apparatus. Release of labeled nucleotide was monitored by the decrease in MABA-ADP fluorescence (excitation 360 nm, emission cutoff filter 400 nm). The curves were analyzed assuming first-order kinetics and a constant drift from bleaching. Rates were determined in triplicate from three independent experiments. b-galactosidase reporter assay. This assay was performed according to an established protocol 31 . Briefly, S. cerevisiae DSY-1100 cells (Genotype MATa leu2-112 ura3-1 trp1-1 his3-11, 15 ade2-1 can1-100 GAL SUC2 carrying plasmids pDS-125 (GR/TRP) and pDS-362 (GRE-lacZ/URA)) were transformed with p423ADH-Hip plasmids. The resultant strains were grown in SC medium lacking histidine, tryptophan and uracil at 30 °C overnight, diluted to OD 600 of 0.05-0.10 and grown at 25 °C for 90 min. Cell growth was monitored spectrophotometrically to ensure that the cells were in the exponential growth phase. Deoxycorticosterone (DOC) was added to a final concentration of 50 nM. 90 min after hormone addition, samples were withdrawn at 15-min intervals, the OD 600 determined and an equal volume of Gal-Screen chemiluminescence reagent (Applied Biosystems) added. After 2 h, reactions were analyzed with a luminometer (Berthold LB 9507). The emitted light was plotted against the OD 600 , and the slope was determined by linear regression as a measure of functional β-galactosidase expression. Cells transformed with p423ADH served as background control.
